Finally, rats exposed to systemically administered LPS and IL-1β show depressive-like behaviour [66], [67], [68] and increased microglial activation in several depression associated brain regions (including hippocampus, amygdala and prefrontal cortex)[17], [69]. This evidence concerns the gene IL1B and depressive symptom measurement.